N

Nexstim Oyj
OMXH:NXTMH

Watchlist Manager
Nexstim Oyj
OMXH:NXTMH
Watchlist
Price: 8.36 EUR 1.95%
Market Cap: 59.9m EUR
Have any thoughts about
Nexstim Oyj?
Write Note

Net Margin
Nexstim Oyj

-10.5%
Current
-19%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-10.5%
=
Net Income
-833.1k
/
Revenue
7.9m

Net Margin Across Competitors

Country FI
Market Cap 56.6m EUR
Net Margin
-11%
Country US
Market Cap 199.9B USD
Net Margin
14%
Country US
Market Cap 191.9B USD
Net Margin
29%
Country US
Market Cap 140.8B USD
Net Margin
16%
Country US
Market Cap 134.7B USD
Net Margin
11%
Country IE
Market Cap 104.7B USD
Net Margin
13%
Country US
Market Cap 65.9B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.8B USD
Net Margin
74%
Country CN
Market Cap 314.4B CNY
Net Margin
33%
Country US
Market Cap 36.4B USD
Net Margin
9%
No Stocks Found

Nexstim Oyj
Glance View

Market Cap
56.6m EUR
Industry
Health Care

Nexstim Oyj engages in the provision of medical technology products. The company is headquartered in Helsinki, Etela-Suomen and currently employs 37 full-time employees. The company went IPO on 2014-11-14. The company is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.

NXTMH Intrinsic Value
6.19 EUR
Overvaluation 26%
Intrinsic Value
Price
N

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-10.5%
=
Net Income
-833.1k
/
Revenue
7.9m
What is the Net Margin of Nexstim Oyj?

Based on Nexstim Oyj's most recent financial statements, the company has Net Margin of -10.5%.